| Unique ID issued by UMIN | UMIN000029995 |
|---|---|
| Receipt number | R000034254 |
| Scientific Title | Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysis |
| Date of disclosure of the study information | 2017/11/16 |
| Last modified on | 2022/11/20 10:20:55 |
Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysis
NCCH-1608
Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysis
NCCH-1608
| Japan |
Lung Cancer
| Pneumology | Hematology and clinical oncology |
Malignancy
YES
Explore the predictive factors for efficacy and safety of osiemrtinib by PK/PD/PGx analysis
Safety,Efficacy
Response Rate
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients aged 20years or older who are diagnosed lung cancer and scheduled to receive osimertinib.
Not applicable
200
| 1st name | |
| Middle name | |
| Last name | Yuichiro Ohe |
National Cancer Center
Thoracic Oncology
5-1-1 Tsukiji Chuoku, Tokyo
0335422511
yohe@ncc.go.jp
| 1st name | |
| Middle name | |
| Last name | Yasushi Goto |
National Cancer Center Hospital
Thoracic Oncology
5-1-1 Tsukiji Chuoku, Tokyo
0335422511
ygoto@ncc.go.jp
National Cancer CEnter
Japan Agency for Medical Research and Development
Japanese Governmental office
NO
| 2017 | Year | 11 | Month | 16 | Day |
Unpublished
No longer recruiting
| 2017 | Year | 04 | Month | 13 | Day |
| 2017 | Year | 06 | Month | 19 | Day |
| 2017 | Year | 06 | Month | 28 | Day |
| 2020 | Year | 06 | Month | 26 | Day |
None
| 2017 | Year | 11 | Month | 16 | Day |
| 2022 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034254